CorticaCare announced on April 18th that it acquired two Behavioral Health Care (BHC) organizations: Springtide Child Development and Melmed Center.
Springtide Child Development offers family-centered, collaborative care for children with developmental delays and disabilities. Its services include ABA, speech, occupational and physical therapies. It has three locations in Connecticut and three in Massachusetts.
Melmed Center provides a compassionate, state of the art approach to the assessment and treatment of behavioral, educational and developmental challenges in children and adults up to the age of 21 years old.
CorticaCare’s doctors provide diagnoses for autism, ADHD, developmental delays and the full range of developmental differences. It is based in California, Connecticut, Massachusetts, Texas, New Jersey and Illinois.
The two acquisitions bring Cortica’s total integrated autism centers in the United States to 23 with more than 1,600 providers. Springtide Child Development is CorticaCare’s first acquisition in Connecticut. The financial terms were not disclosed.
According to data captured in the LevinPro HC database, this acquisition marks the 22nd BHC acquisition of the year, and the fourth in the autism specialty.
